Freya Biosciences

Freya will be at the 9th Microbiome Movement in Boston, July 10-12 (https://lnkd.in/ddhHiQJ). Colleen Acosta, Freya’s CEO will give a presentation on Friday, July 12 entitled “Pioneering a New Class of Microbial Immunotherapies for Women’s Health“. Ulrich Binné, CBO, Crilles Casper Larsen, SVP CMC & Quality, and Kevin DeLong, Senior Scientist will also attend. We look forward to seeing our colleagues at the meeting.

Our CSO Johan E.T. van Hylckama Vlieg will be presenting recent clinical data obtained from vaginal microbiota transplants (VMT) without antibiotic pretreatment in women with asymptomatic dysbiosis at the ESHRE annual meeting European Society of Human Reproduction and Embryology (ESHRE) #ESHRE2024 #womenshealth #fertility #reproductivehealth #immunotherapy #microbiome #microbiota

We at Freya have posted a manuscript on https://lnkd.in/gvAGmMV8 describing our clinical trial DYSCOVER-1 investigating vaginal microbiota transplantation (VMT) for successful dysbiosis resolution. Together with a companion paper by Henriette Svarre Nielsen and team these are the first randomized placebo-controlled VMT clinical trials. Both manuscripts are submitted for peer review, but we are making the studies available here now to the scientific community and to our highly engaged study participants, without whom this would not have been possible! #womenshealth #microbiome #microbiota #immunotherapy #worldmicrobiomeday

We are proud to be recognized by Sifted for our innovation! A special thank you to all of our partners who provide us with support so we may continue to deliver groundbreaking work.

Here's to all the incredible mothers—may your day be filled with love, joy, and cherished moments. At Freya Bioscience, we're rewriting the story of maternity. Together, let's redefine what's possible. Happy Mothers Day.

Thanks so much to The Medicine Maker and Stephanie Vine (formerly Sutton) for this feature on our work at Freya Biosciences in developing new therapeutics for women!

We welcome Laura Ensign, one of Freya’s co-founders and our SAB chair to Copenhagen. Click on the link and register: https://lnkd.in/dFk62dU2

Join us in Copenhagen, Denmark, from April 9th to 11th, 2024, for the Microbiomes in Women's Health Congress. Johan van Hylckama Vlieg, our CSO and co-founder is a member of the Organizing Committee. Don't miss this opportunity to network, learn, and contribute to the future of women's health. Freya will be present and looks forward to greeting many of our colleagues and friends in Copenhagen

Today we celebrate Women's Day. A time to recognize the achievements, struggles and contributions of women around the world. Let's carry on supporting and promoting equality, and making sure that, day after day, through our work, more and more women live healthy and happy lives. #happywomensday

We are excited to announce that Johan E.T. van Hylckama Vlieg, Chief Scientific Officer and co-founder of Freya Biosciences was featured in Labiotech’s podcast series: “Beyond Biotech.” Listen to the podcast interview here: https://lnkd.in/gU8g6QpV